|
|
Moving Toward Real Solutions:
Advances to Address Low Health Literacy
2006 Conference Home Agenda Speakers
Fifth Annual National Health Communication Conference
Co-Sponsored by the Institute of Medicine
November 29, 2006
National Academy of Sciences
2100 C Street NW, Washington, DC
Conference Executive Summary
Speakers
Jill A. Berger, MSA
Corporate Health Plan Strategies and Health Literacy
Jill A. Berger, MSA is the Vice-President, Health & Welfare Plan Management and Design for Marriott International, a leading hospitality company with 130,000 employees nationwide. Ms. Berger is responsible for the strategy, design and management of Marriott's benefit plans, with an emphasis in health plan quality improvement. She serves on the National Committee for Quality Assurance Purchaser Advisory Council, is an active member of the Leapfrog Group for Patient Safety, and serves on the Executive Client Advisory Groups for Aetna, Kaiser and eValue8.
Prior to working for Marriott, she was with Kaiser Permanente, working in conjunction with General Motors as a Health Plan Manager. She managed the health plans in the eastern part of the U.S., representing 400,000 GM employees and retirees. Prior to working with General Motors, Jill managed the medical plans for Sears, Roebuck and Company. Jill obtained her Bachelor of Arts degree from Mount St. Mary's College and her MSA from Johns Hopkins University.
Lisa Cooper, MD, MPH
Health Literacy and High Blood Pressure Control Among Ethnic Minorities and Poor Persons Receiving Care in Urban Primary Care Clinics
Lisa A. Cooper, MD, MPH is an Associate Professor of Medicine, Epidemiology and Health Behavior and Society at the Johns Hopkins University School of Medicine and Bloomberg School of Public Health. She is a board-certified general internist, health services and outcomes researcher, and medical educator, as well as a member of The Johns Hopkins Hospital Medical Staff.
Dr. Cooper's research has examined patient-centered strategies for improving outcomes and overcoming racial and ethnic disparities in healthcare. Her work has better defined the roles of patient-physician communication, physician cultural competence, and patient attitudes in understanding and eliminating disparities in healthcare. Dr. Cooper has authored several articles and book chapters including a chapter on patient-physician communication published in the Institute of Medicine's 2003 Report, "Unequal Treatment."
She is currently implementing and evaluating the impact of interventions that target physicians and patients to improve the quality of communication, treatment, outcomes for cardiovascular disease and depression in primary care settings.
Terry C. Davis, PhD
Literacy and Misunderstanding of Medication Labels
Terry C. Davis, PhD, a pioneer in the field of health literacy, is Professor of Medicine and Pediatrics at Louisiana State University (LSU) Health Sciences Center in Shreveport, L.A., where she also heads the Behavioral Science Unit of the Feist-Weiller Cancer Center. Among her faculty responsibilities, Dr. Davis directs the Doctor/Patient Communication course for medical students and Internal Medicine residents. For the past 20 years, Dr. Davis has led an interdisciplinary team investigating the impact of patient literacy on health and healthcare.
Dr. Davis was awarded the Louisiana Public Health Association's Founders Award for Significant Achievement in Public Health Research. In 2003, she was asked to chair Louisiana's statewide Health Literacy Task Force, the first legislatively mandated health literacy group in the nation. Her current research activities include collaboration with investigators at Northwestern University and Emory University on health literacy, medication safety and labeling concerns. She is also working with investigators at the University of North Carolina and the University of California at San Francisco on implementation and dissemination of a novel diabetes self- management toolkit they created with patients and providers. The diabetes project is funded by the ACP Foundation and Novo Nordisk. She is also chair of the American College of Physicians Foundation's Patient-Centered Health Literacy Advisory Board.
Harold J. Fallon, MD, MACP
Introductions and Opening Remarks
Harold J. Fallon, MD, MACP is the former Home Secretary of the Institute of Medicine. Prior to this he served as Dean of the University of Alabama School of Medicine and Associate Dean for Graduate Medical Education. His major clinical and clinical research interests have focused on liver diseases. He helped to found liver sections at the University of North Carolina and the Medical College of Virginia and supported the development of the Liver Center at the University of Alabama. He graduated from Yale Medical School in 1957 and was an intern and resident in Internal Medicine at the University of North Carolina in Chapel Hill. He was a Clinical Associate at the National Cancer Institute of the NIH 1959-1961 and thereafter was chief resident at Chapel Hill.
Dr. Fallon has been a member of numerous academic societies, especially in Internal Medicine and Hepatology. He is past President of the Southern Society for Clinical Investigation, Vice President of the American Society for Clinical Investigation, President of the American Association of Physicians, Chairman of the American Board of Internal Medicine, Chairman of the Board of Regents of the American College of Physicians, Chairman of the Residency Review Committee in Internal Medicine, and President of the American Association for the Study of Liver Disease. He has served on the Governing Board of the American Gastroenterology Association and on the Editorial Boards of Hepatology, Gastroenterology, The Journal of Clinical Investigation and Lipids. He was elected to the Institute of Medicine of the National Academy of Sciences in 1989. He was a member of the Membership Committee and its Chairman from 1995 through 1998.
Charles Ganley, MD
Over-the-Counter Drug Product Labeling
Charles Ganley, MD is a graduate from the University of Pittsburgh with a Bachelor of Science degree in Chemistry. He obtained his medical degree from Hahnemann University Medical College and completed residency training in Internal Medicine at Hahnemann Hospital. He is board certified in Internal Medicine. Upon the completion of residency training, he fulfilled a Public Health Service obligation and then went on to a clinical pharmacology fellowship at Cornell University Medical Center. Dr. Ganley started his career at the Food and Drug Administration (FDA) in 1989 as a medical reviewer in the Division of Cardio-Renal Drug Products (DCRDP). He served as a medical team leader in the DCRDP prior to becoming the Director of the Division of Over-the-Counter Drug Products (DOTCDP) in 1999. In 2005, the DOTCDP was reorganized into the Office of Nonprescription Drug Products (ONP). Dr. Ganley is currently the Director of the ONP at the FDA. ONP is responsible for evaluating the availability and labeling of nonprescription drug products in the United States.
Andrea Gelzer, MD, MS, FACP
Making the Business Case for Communication
Dr. Andrea Gelzer is Senior Vice President for Clinical Public Affairs at CIGNA. She provides strategic guidance for the enterprise and leads public policy development, identifying and addressing emerging health care issues of global concern. She also serves as the principal liaison to medical professional societies, trade organizations, legislative bodies, and advocacy groups and articulates the company's initiatives to improve health outcomes, assure patient safety, and provide integrated patient-centered health benefits.
Dr. Gelzer completed her undergraduate work at Tufts University and medical school at St. George's University. She received an MS degree in Administrative-Preventive Medicine at the University of Wisconsin, Madison. Dr. Gelzer currently serves on the March of Dimes' national Public Policy Advisory Council and is a liaison representative to the CDC's Advisory Committee on Immunization Practices. She is an incorporator of eHealthConnecticut and also serves as a commissioner for the Certification Commission for Health Information Technology.
Ron Z. Goetzel, PhD
The Business Case for Health and Productivity Management: What's the Return on Investment?
Ron Z. Goetzel, PhD is both the founding Director of the Cornell University Institute for Health and Productivity Studies and Vice President of Consulting and Applied Research at Thomson Medstat. At both Cornell and Medstat, Dr. Goetzel is responsible for leading innovative research projects and consulting services for healthcare purchaser, managed care, government, and pharmaceutical clients interested in conducting cutting-edge research focused on the relationship between health and well-being, and work-related productivity. He is a nationally recognized and widely published expert in health and productivity management, return-on-investment (ROI), data analysis, program evaluation and outcomes research.
Before joining Medstat in 1995, Dr. Goetzel was Vice President of Assessment, Data Analysis and Evaluation Services at Johnson & Johnson Health Care Systems. Dr. Goetzel earned his doctorate in Organizational and Administrative Studies and his M.A. in Applied Social Psychology from New York University (NYU), and his B.S. degree in Psychology from the City College of New York (CCNY)
George Isham, MD, MS
The Institute of Medicine's Roundtable on Health Literacy
George Isham, MD, MS is the Medical Director and Chief Health Officer at HealthPartners. He is responsible for quality, utilization management, health promotion and disease prevention, research, and health professionals' education and is active in strategic planning and policy issues.
Dr. Isham is a founding board member of the Institute for Clinical Systems Improvement, a collaborative of Twin Cities medical groups and health plans that is implementing clinical practice guidelines in Minnesota. Dr. Isham currently serves as the chair of the IOM's Health Literacy Roundtable.
Dr. Isham received a Bachelor of Arts in Zoology and Master of Science in preventive medicine/administrative medicine from the University of Wisconsin Madison and his MD from the University of Illinois.
Michael D. Murray, PharmD, MPH
Effects of a Multilevel Pharmacy-based Intervention on Medication Adherence and Health Outcomes in Low-income Patients with Heart Failure
Michael D. (Mick) Murray, PharmD, MPH is Mescal S. Ferguson Distinguished Professor at the University of North Carolina at Chapel Hill where he serves as Chair of the Pharmaceutical Outcomes & Policy Division and Director of the Center for Pharmaceutical Outcomes & Policy.
Dr. Murray's research involves developing pharmacy services to improve drug therapy in older adults with chronic disorders, health care utilization of low-income minority people, and pharmacoepidemiology using large population computer databases. His research has been funded by the Agency for Healthcare Research and Quality and the National Institutes of Health. Active projects include the measurement of patient adherence to prescribed medications and developing interventions to improve the use of medications in adults with chronic disorders such as heart failure and hypertension. In 1996 Dr. Murray received the Award for Excellence in Health Science Research from the Indiana Public Health Foundation, in 1999 he was named a Purdue University Faculty Scholar, and in 2002 he was named Bucke Professor of Pharmacy. From 1996 to 2004 he served as Director of Healthcare Data & Epidemiology and Senior Scientist at the Regenstrief Institute.
Alan R. Nelson, MD, MACP
The Business Case Session
Alan R. Nelson, MD, MACP serves as Chair of the ACP Foundation Board of Trustees. Dr. Nelson is an internist-endocrinologist who was in private practice in Salt Lake City, Utah until becoming chief executive officer of the American Society of Internal Medicine (ASIM) in 1992. He was president of the American Medical Association in 1989-90, after serving as chair of the AMA Board of Trustees and was president of the World Medical Association from 1991-1992.
A member of the prestigious Institute of Medicine of the National Academy of Sciences (IOM), Dr. Nelson serves on the IOM Roundtable on Environmental Health Sciences Research and Medicine, and was co-chair of the Workshop Planning Group on the Environment and Cancer. He also was Chair of an IOM committee on Ethnic and Racial Disparities in Health Care and is a co-editor of the study report, Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care.
Among the awards and honors that Dr. Nelson has received are Distinguished Internist of the American Society of Internal Medicine, Mastership in the American College of Physicians, the Coble Award of the American Association of Clinical Endocrinologists, Distinguished Alumnus of Northwestern University School of Medicine, the Perry A. Lambird Excellence in Medicine Award, and the Boyle Award for Distinguished Public Service from ACP-ASIM.
Raymond L. Ownby, MD, PhD, MBA
Using Information Technology to Accommodate Patients' Levels of Health Literacy
Raymond L. Ownby, MD, PhD, MBA is a Professor in the Department of Psychiatry and Behavioral Sciences at the University of Miami Miller School of Medicine. He is currently developing a Center for Evidence-Based Clinical Practice at the University of Miami, the purpose of which will be to support research projects that inform clinical interventions in mental health. The Center will also provide information and education on evidence-based clinical practice to the University community.
Dr. Ownby has the distinction of having been trained both as a psychiatrist and clinical neuropsychologist, facilitating his work in cognition and mood. He is a graduate of the University of Miami, Master of Business Administration program in Health Care Policy and Administration. His research interests include relations between cognition and mood in the elderly, the psychoneuroendocrinology of cognitive and mood disorders, and economic evaluation of health care interventions.
Ruth Parker, MD, FACP
Literacy and Misunderstanding of Prescription Drug Labels
Ruth Parker, MD, FACP is a Professor of Medicine at the Emory University School of Medicine as well an Associate Director of the Faculty Development program. She holds a secondary appointment at the Emory University School of Public Health in the Division of Epidemiology.
Over the last 10 years, Dr. Parker has focused extensively on healthcare issues of underserved populations, particularly health literacy. She was a principal investigator in the Robert Wood Johnson Literacy in Health Study and helped create a measurement tool to quantify patients' ability to read and understand health information. She has authored numerous papers on health literacy, and co-edited the complete bibliography of medicine on health literacy for the National Library of Medicine.
Dr. Parker was instrumental in establishing the ACP Foundation's focus on health literacy and served as the first chair of the Foundation's Patient-Centered Health Litreracy Advisory Board. She currently chairs the ACP Foundation's Programs Committee and is a member of the Institute of Medicine's Committee on Health Literacy. She chaired the expert panel for the Council of Scientific Affairs for the AMA that authored the frequently-cited JAMA white paper on health literacy. She is currently chair of the steering committee for the AMA Foundation’s national signature program on health literacy.
Dr. Parker attended Davidson College and received her medical training at the University of North Carolina, Chapel Hill. She completed her residency and chief residency at the Strong Memorial Hospital in Rochester, New York, and her fellowship as a Robert Wood Johnson Foundation Clinical Scholar at the University of Pennsylvania. She holds Board Certification in both Internal Medicine and Pediatrics.
Barbara Schuster, MD, MACP
Current Research in Advances to Solutions of the Problems of Low Health Literacy
Barbara Schuster, MD, MACP is a Professor and Chair of the Department of Medicine at Wright State University. She completed her B.A. in biology and a M.S. in Science Education at the University of Pennsylvania. After a year teaching in a public high school, she returned to medical school completing her M.D. at the University of Rochester in 1977. Dr. Schuster completed her residency in Internal Medicine in the Associated Hospitals Program in Rochester, New York and then served on the faculty of the University of Rochester until 1995. Prior to her move to Dayton, Ohio, she held the positions of residency program director for the Primary Care Program in Internal Medicine and the Combined Internal Medicine/Pediatrics Program.
Dr. Schuster is the President of the Association of Professors of Medicine (APM). She served as the Chair of the Council of Academic Societies (CAS) of the Association of American Medical Colleges (AAMC) in 2003-04, and continues as the APM representative to the CAS. She served six years on the Executive Council of the AAMC. Dr. Schuster is actively involved in the American College of Physicians. As a Regent from 1999 through 2005, she served on the Recertification Committee, the Nominations Committee, was the 1999 to 2000 Chair of the Awards Committee, and from 2001 to 2005 was Chair of the ACP Education Committee. She is currently a member of the ACP Foundation Programs Committee and the Conference Planning Subcommittee.
William H. Shrank, MD, MSHS
Providing our Patients with Better Information about their Medications: A Report on the Prescription Drug Labeling Project
William H. Shrank, MD, MSHS is an Instructor at the Harvard University School of Medicine as well as an Instructor in the Division of Pharmacoepidemiology and Pharmacoeconomics at the Brigham and Women's Hospital. Dr. Shrank received his bachelors degree from Brown University in 1993, his medical degree from Cornell University Medical College in 1998 and completed his internship and residency in Internal Medicine at Georgetown University Hospital in Washington, DC. Dr. Shrank served on the clinical faculty at the University of Colorado Health Sciences Center in the Division of General Internal Medicine in 2001-2. In 2005, he completed a Health Services Research and Development fellowship at UCLA and the West Los Angeles VA Hospital and earned his Masters degree in health services in 2004 from UCLA.
Dr. Shrank has led projects aimed at better understanding how market forces impact adherence to prescription drugs, how pharmacy benefit design impacts prescription drug care, and whether doctors and patients communicate about costs of prescription drugs. He has also been active in measuring the quality of prescription drug care in the United States. He is currently serving as co-Principal Investigator of the American College of Physicians Foundation's on-going Prescription Bottle Labeling Project.
Susanne A. Stoiber, MPA, MSc
Greetings from the Institute of Medicine & Update on the IOM Health Literacy Roundtable
Susanne A. Stoiber, MPA, MSc has served since 1975 in a series of senior positions in the National Academies and the U.S. Department of Health and Human Services. She was named Executive Director (Chief Operating Officer) of the Institute of Medicine in 1998. Her responsibilities include management of the IOM program operations, and support of the Institute's governance and membership functions.
In the Department of Health and Human Services, Mrs. Stoiber held a number of senior positions in the Office of the Secretary and at the National Institutes of Health. She was three times appointed as a Deputy Assistant Secretary for Health -- Planning and Evaluation (1979 and 1995); Health Promotion and Disease Prevention (1996); and as a Deputy Assistant Secretary for Planning and Evaluation, Program Systems (1997). Accomplishments included: coordination of Healthy People 2010 - the nation's prevention agenda; oversight of the Department's evaluation program and GPRA-related strategic planning.
She received her Bachelor of Arts and Master of Public Administration degrees from the University of Colorado, and a Master of Science degree from the London School of Economics.
Pascale S.Thomas
The Business Case for Health Improvement at Verizon
Pascale Thomas has over fifteen years experience in human resources, employee benefits and insurance. She currently works for Verizon Communications as Director-Healthcare in the Corporate Human Resources organization. Pascale’s primary responsibility is to manage the strategy, design, and implementation of Verizon’s health plan offerings to more than 800,000 employee’s, retirees, and dependents, including health improvement, prescription drugs and behavioral health programs. Together with Verizon’s national and state government relations groups and other stakeholders, Pascale develops quality initiatives and monitors healthcare public policy to ensure that these activities are beneficial to Verizon in the long run. She is also responsible for launching a Health Improvement initiative that is intended to drive significant long-term change in the Verizon culture by impacting health and healthcare costs, and empowering employees and their families to become better informed consumers of healthcare services. Pascale also manages internal communications to employees, and coordinates external communication in relation to Verizon’s corporate citizenship role in healthcare.
Prior to joining Verizon, Pascale worked for PricewaterhouseCoopers LLP (PWC) as a project manager and consultant to their Global HR Solutions practice. Her professional experience also includes eight years as a Risk Manager and Insurance broker to corporate clients. Pascale is active in a number of quality initiatives, including the National Business Group in Health's Leadership Committee on Consumer-Directed Health Care, the board of Bridges of Excellence, and eHealth Initiative's Employer Purchaser Advisory Board.
Barry D. Weiss, MD
Literacy Enhancement for Treatment of Depression in Patients with Depression and Limited Literacy: A Randomized Controlled Trial
Barry D. Weiss, MD is a professor in the Department of Family and Community Medicine at the University of Arizona College of Medicine. He has been involved in the fields of health literacy and patient-physician communication for much of his professional career. His writings on this topic have been published in the New England Journal of Medicine, the Journal of the American Medical Association, and a variety of other books and medical journals.
Dr. Weiss wrote the American Medical Association's Health Literacy Manual for Physicians and a chapter for the Association's recent health literacy textbook. He has served on health literacy advisory committees for the American College of Physicians, the American Medical Association Foundation, the National Cancer Institute, the Moffitt Cancer Center and Research Institute, and the Pfizer Health Literacy Initiative. He was a consultant to the Institute of Medicine's Committee on Health Literacy and wrote a portion of the Institute'ss health literacy report.
Dr. Weiss is the editor of Family Medicine, national journal of the Society of Teachers of Family Medicine, and associate editor of FP Essentials, the American Academy of Family Physicians' home study monograph program. He is also deputy editor of Micromedex's Best Practice of Medicine on-line database, and series editor of McGraw-Hill's 20 Common Problems textbook series, which includes Dr. Weiss's texts on 20 Common Problems in Primary Care and 20 Common Surgical Problems and Procedures in Primary Care.
Dr. Weiss is board certified in family medicine and holds a certificate of added qualification in geriatric medicine.
Michael S. Wolf, PhD, MPH
Evidence-Based Approach to Improved Medication Labeling
Michael S. Wolf, PhD, MPH is an Assistant Professor of Medicine, Institute for Healthcare Studies, and Director of the Health Literacy and Learning Program (HeLP) within the Feinberg School of Medicine, Northwestern University. He is a social/behavioral scientist and health services researcher with expertise in health literacy, learning and cognition, health behavior, and health disparities. Dr. Wolf received the Pfizer Health Literacy Initiative Scholar Award (2002), the Pfizer Health Literacy Visiting Lecturer (2003), and the Institute for Healthcare Advancement Outstanding Health Literacy Research award (2004). He is funded by the Centers for Disease Control and Prevention (K01 EH000067-01, PI: Wolf) to investigate causal pathways linking low health literacy to outcomes, and to develop multimedia/enhanced print tools to teach self care concepts. He is a member of the Joint Commission on the Accreditation of Hospital Organizations roundtable on Health Literacy and Patient Safety, the American College of Physicians Foundation Prescription Medication Labeling Advisory Board, the American Medical Association's expert panel on chronic disease management for vulnerable populations, Medicaid Consumer Information Committee, and advises the Food & Drug Administration on health literacy matters. Dr. Wolf has published numerous health literacy-related articles, and is the guest editor of the upcoming special health literacy issue of the American Journal of Health Behavior.
Alastair Wood, MD, FACP
Prescription Bottle Labeling Session
Alastair Wood, MD, FACP received his medical degree from St Andrew’s University and Dundee Medical School in Scotland. After clinical training in Internal Medicine he undertook fellowship training at Vanderbilt Medical School from 1976-78; in 1978 he joined the Vanderbilt Faculty and has remained there until now. He is a tenured Professor of both Medicine and Pharmacology and Attending Physician at Vanderbilt Medical School. He was Assistant Vice Chancellor for Clinical Research (1999-2004), and is now the Associate Dean, Vanderbilt Medical School.
Dr. Wood is a member of many societies and has received numerous honors, including election to membership of The American Association of Physicians (AAP), The American Society for Clinical Investigation (ASCI), Honorary Fellow, American Gynecological and Obstetrical Society (AGOS), Fellowship of The American College of Physicians, Fellowship of The Royal College of Physicians of London, and Fellowship of The Royal College of Physicians of Edinburgh. He was the 2005 recipient of the Rawls-Palmer Award in recognition of "drug investigation that brings the effects of modern drug research to the care of patients" from the American Society for Pharmacology and Therapeutics.
Dr. Wood serves on a number of Editorial Boards; most notably he is a member of The New England Journal of Medicine Editorial Board; he was the Drug Therapy Editor of The New England Journal of Medicine from 1985 to 2004, and is also on the Editorial Board of Clinical Pharmacology and Therapeutics. He has previously served on the Editorial Boards of The British Journal of Clinical Pharmacology and Biopharmaceutics and Drug Disposition. He authored the Chapter in Harrison's Principles of Internal Medicine on Adverse Drug Reactions from the 9th through the 15th edition.
Dr. Wood is currently the chairman of the FDA's Nonprescription Drugs Advisory Committee, and recently chaired the FDA Advisory Committee on Cox-2 inhibitors. He previously served as a member of the Cardiovascular and Renal Advisory Committee of the Food and Drug Administration, and the FDA's Nonprescription Drugs Advisory Committee. Dr. Wood has also been both a member, and has chaired NIH Study Sections, and has served in a similar capacity for various philanthropic grant-giving bodies. He is a director of two pharmaceutical companies Antigenics (AGEN), and Symphony Neurodevelopment, and has served as a consultant to pharmaceutical companies, investors and academic institutions. He has provided Congressional testimony, and directly interacted with and advised senior White House officials, legislators, and the Secretary of Health on matters related to public health. He is a frequent commentator in the national press on issues related to medicine and pharmaceuticals.
|
